Wahl Bryan — SEC Form 4 filings
SEC reporting owner CIK 1841401. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-11 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 3 filings — 26,562 shares, $1,449,924 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 4,084 shares @ $69.42 ($283,511) in Tarsus Pharmaceuticals, Inc., filed 2026-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | 8 | — | 7 legs · 26,562 sh · $1,449,924 | 18 |
Form 4 filings — Wahl Bryan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 4,084 @ $69.42 · Sale (S): 4,125 @ $68.71 · Sale (S): 4,231 @ $67 | EDGAR |
| 2026-03-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 24,236 · Option exercise (M): 4,790 (derivative) @ $0 · Option exercise (M): 7,248 (derivative) @ $0 · Option exercise (M): 7,176 (derivative) @ $0 · Option exercise (M): 5,022 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 27,310 (derivative) @ $0 · Grant/award (A): 17,161 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 3,341 @ $46.29 · Sale (S): 3,261 @ $47.40 · Sale (S): 3,084 @ $50.11 | EDGAR |
| 2025-03-18 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 19,213 · Option exercise (M): 4,790 (derivative) @ $0 · Option exercise (M): 7,248 (derivative) @ $0 · Option exercise (M): 7,175 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 30,628 (derivative) @ $0 · Grant/award (A): 20,089 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 12,038 · Sale (S): 4,436 @ $30.60 · Option exercise (M): 4,790 (derivative) @ $0 · Option exercise (M): 7,248 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 42,500 (derivative) @ $0 · Grant/award (A): 28,702 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1841401 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →